Literature DB >> 9858316

Induction of interferon synthesis and activation of interferon-stimulated genes by liposomal transfection reagents.

X L Li1, M Boyanapalli, X Weihua, D V Kalvakolanu, B A Hassel.   

Abstract

Liposome-mediated transfection is a widely used technique for the introduction of exogenous DNA into mammalian cells. We observed a significant induction of endogenous interferon (IFN)-stimulated genes (ISGs) in cells treated with the liposomal reagents, lipofectamine and DOSPER, in the absence of DNA. Liposome treatment induced expression of reporter constructs driven by IFN-responsive promoter elements, demonstrating a generalized effect on ISG expression. The kinetics of ISG induction were markedly delayed in response to liposome as compared with IFN or double-stranded RNA. ISG induction could be transferred to naive cells with conditioned medium from liposome-treated cells, suggesting that a secreted factor was responsible for this activity. A cell line defective in IFN signaling was refractory to liposome-induced ISG expression, indicating a role for IFN in this induction. Indeed, liposome treatment directly induced IFN-beta gene expression and, thus, represents a novel IFN inducer. IFN induction by liposomal reagents and its potential effects on transgene expression should be considered in the choice of transfection reagent. The ability of liposomal gene delivery reagents to induce IFN synthesis in the host may prove useful in gene therapy approaches to viral and neoplastic diseases.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9858316     DOI: 10.1089/jir.1998.18.947

Source DB:  PubMed          Journal:  J Interferon Cytokine Res        ISSN: 1079-9907            Impact factor:   2.607


  9 in total

1.  Cell fusion-induced activation of interferon-stimulated genes is not required for restriction of a herpes simplex virus VP16/ICP0 mutant in heterokarya formed between permissive and restrictive cells.

Authors:  Meaghan H Hancock; Karen L Mossman; James R Smiley
Journal:  J Virol       Date:  2009-06-17       Impact factor: 5.103

2.  Role of interferon-stimulated gene factor 3gamma and beta interferon in HLA class I enhancement in synovial fibroblasts upon infection with Chlamydia trachomatis.

Authors:  Jürgen Rödel; Heinz Vogelsang; Katrin Prager; Matthias Hartmann; Karl-Hermann Schmidt; Eberhard Straube
Journal:  Infect Immun       Date:  2002-11       Impact factor: 3.441

3.  Regulation of TLR2 expression and function in human airway epithelial cells.

Authors:  Tamene Melkamu; Diane Squillace; Hirohito Kita; Scott M O'Grady
Journal:  J Membr Biol       Date:  2009-06-10       Impact factor: 1.843

4.  Host cell cytokines induced by Chlamydia pneumoniae decrease the expression of interstitial collagens and fibronectin in fibroblasts.

Authors:  Jürgen Baumert; Karl-Hermann Schmidt; Annett Eitner; Eberhard Straube; Jürgen Rödel
Journal:  Infect Immun       Date:  2008-12-01       Impact factor: 3.441

5.  Electroporation formulation for cell therapy.

Authors:  Jiemiao Hu; Shulin Li
Journal:  Methods Mol Biol       Date:  2014

6.  Innate cellular response to virus particle entry requires IRF3 but not virus replication.

Authors:  Susan E Collins; Ryan S Noyce; Karen L Mossman
Journal:  J Virol       Date:  2004-02       Impact factor: 5.103

7.  IFI16 restricts HSV-1 replication by accumulating on the hsv-1 genome, repressing HSV-1 gene expression, and directly or indirectly modulating histone modifications.

Authors:  Karen E Johnson; Virginie Bottero; Stephanie Flaherty; Sujoy Dutta; Vivek Vikram Singh; Bala Chandran
Journal:  PLoS Pathog       Date:  2014-11-06       Impact factor: 6.823

8.  Induction of CC-chemokines with antiviral function in macrophages by the human T lymphotropic virus type 2 transactivating protein, Tax2.

Authors:  Glorilee Balistrieri; Christy Barrios; Laura Castillo; Tochi C Umunakwe; Chou-Zen Giam; Huijun Zhi; Mark A Beilke
Journal:  Viral Immunol       Date:  2013-01-03       Impact factor: 2.257

9.  Cationic liposome-mediated enhanced generation of human HLA-restricted RSV-specific CD8+ CTL+.

Authors:  Innocent N Mbawuike; Yongxin Zhang; Ying Wang; Ling Song
Journal:  J Clin Immunol       Date:  2002-05       Impact factor: 8.542

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.